Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) announced that, following communication with the U.S. Food and Drug Administration (FDA), the Company has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE